Literature DB >> 7387405

Gene constellation of live influenza A vaccines.

G Florent.   

Abstract

The genotypic composition of several H3N2 vaccinal strains made from PR/8/34 and different wild isolates has been determined. The results suggested that specific gene constellations at the level of the 3 largest RNA fragments, coding the 3 "polymerase proteins" are responsible for their consistent attenuation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7387405     DOI: 10.1007/bf01318021

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  6 in total

1.  RNAs of influenza virus recombinants derived from parents of known virulence for man.

Authors:  G Florent; M Lobmann; A S Beare; N Zygraich
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

2.  The genes of influenza virus.

Authors:  P Palese
Journal:  Cell       Date:  1977-01       Impact factor: 41.582

3.  Procedures for characterisation of the genetic material of candidate vaccine strains.

Authors:  A J Hay; A R Bellamy; G Abraham; J J Skehel; C M Brand; R G Webster
Journal:  Dev Biol Stand       Date:  1977 Jun 1-3

4.  Trials in man with live recombinants made from A/PR/8/34 (H0 N1) and wild H3 N2 influenza viruses.

Authors:  A S Beare; G C Schild; J W Craig
Journal:  Lancet       Date:  1975-10-18       Impact factor: 79.321

5.  Correlation of pathogenicity and gene constellation of influenza A viruses. III. Non-pathogenic recombinants derived from highly pathogenic parent strains.

Authors:  R Rott; M Orlich; C Scholtissek
Journal:  J Gen Virol       Date:  1979-08       Impact factor: 3.891

6.  Recombinant influenza-A viruses as live vaccines for man. Report to the Medical Research Council's Committee on Influenza and other Respiratory Virus Vaccines.

Authors:  A S Beare; T S Hall
Journal:  Lancet       Date:  1971-12-11       Impact factor: 79.321

  6 in total
  14 in total

1.  The avian influenza virus nucleoprotein gene and a specific constellation of avian and human virus polymerase genes each specify attenuation of avian-human influenza A/Pintail/79 reassortant viruses for monkeys.

Authors:  M H Snyder; A J Buckler-White; W T London; E L Tierney; B R Murphy
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

2.  Molecular characteristics and biological properties (genetic markers) of candidate strains for preparation of live influenza virus vaccines.

Authors:  Y Z Ghendon
Journal:  Bull World Health Organ       Date:  1984       Impact factor: 9.408

3.  Plaquing characteristics of influenza A virus recombinants of defined genetic composition. Brief report.

Authors:  J S Oxford; K A Callow; T Corcoran; A S Beare
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

4.  Use of single-gene reassortant viruses to study the role of avian influenza A virus genes in attenuation of wild-type human influenza A virus for squirrel monkeys and adult human volunteers.

Authors:  M L Clements; E K Subbarao; L F Fries; R A Karron; W T London; B R Murphy
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

5.  A determinant of polyomavirus virulence enhances virus growth in cells of renal origin.

Authors:  J B Bolen; S E Fisher; K Chowdhury; T C Shan; J E Williams; C J Dawe; M A Israel
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

6.  The influence of the multi-basic cleavage site of the H5 hemagglutinin on the attenuation, immunogenicity and efficacy of a live attenuated influenza A H5N1 cold-adapted vaccine virus.

Authors:  Amorsolo L Suguitan; Michael P Marino; Purvi D Desai; Li-Mei Chen; Yumiko Matsuoka; Ruben O Donis; Hong Jin; David E Swayne; George Kemble; Kanta Subbarao
Journal:  Virology       Date:  2009-10-14       Impact factor: 3.616

7.  Genetic content of Influenza H3N2 vaccine seeds.

Authors:  Corinne Bergeron; Martine Valette; Bruno Lina; Michele Ottmann
Journal:  PLoS Curr       Date:  2010-09-05

8.  Attenuated strains of influenza A viruses do not induce degradation of RNA polymerase II.

Authors:  Ariel Rodriguez; Alicia Pérez-González; M Jaber Hossain; Li-Mei Chen; Thierry Rolling; Pilar Pérez-Breña; Ruben Donis; Georg Kochs; Amelia Nieto
Journal:  J Virol       Date:  2009-08-19       Impact factor: 5.103

9.  The amantadine-sensitivity of recombinant and parental influenza virus strains.

Authors:  M Hamzawi; R Jennings; C W Potter
Journal:  Med Microbiol Immunol       Date:  1981       Impact factor: 3.402

10.  Live influenza A/Victoria/75 (H3N2) virus vaccines: reactogenicity, immunogenicity, and protection against wild-type virus challenge.

Authors:  T R Cate; R B Couch
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.